High-dose epidural infusion of opioids for cancer pain: Cost issues

Journal of Pain and Symptom Management

Volumn 13, Issue 2, 1997, Pages 118-121

  Manfredi, Paolo L ^a   Chandler, Sonja W ^a   Patt, Richard ^a   Payne, Richard ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Cancer; cost; epidural; fentanyl; intraspinal; morphine; opioid; pain; sufentanil

Indexed keywords

BUPIVACAINE; MORPHINE DERIVATIVE; OPIATE; SUFENTANIL;

ADULT; ARTICLE; CANCER PAIN; CASE REPORT; COST BENEFIT ANALYSIS; DECISION MAKING; DRUG COST; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRASPINAL DRUG ADMINISTRATION; MALE; SIDE EFFECT;

ADULT; ANALGESIA, EPIDURAL; ANALGESICS, OPIOID; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; NEOPLASMS; PAIN;

EID: 0030910503     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(96)00266-7     Document Type: Article

References (18)

1. World Health Organization (WHO). Cancer pain relief. Geneva: WHO, 1986.
2. World Health Organization (WHO). Cancer pain relief and palliative care: report of a WHO expert committee. Geneva: WHO, 1990.
3. Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F. A validation study of the WHO method for cancer pain relief. Cancer 1987;59:851-856.
4. Schug SA, Zech D, Dorr U. Cancer pain management according to WHO guidelines. J Pain Symptom Manage 1990;1:27-32.
5. Takeda F. Results of field testing in Japan of the WHO Draft Interim Guideline on Relief of Cancer Pain. Pain Clin 1986;1:83-89.
6. Grond S, Zech D, Schug SA, Lynch J, Lehman KA. Validation of the World Health Organization guidelines for cancer pain relief during the last days and hours of life. J Pain Symptom Manage 1991;6: 411-422.
7. Pert CB, Snyder S. Opiate receptor demonstration in nervous tissue. Science 1973;179:1011-1014.
8. Atweh SF, Kuhar MJ. Autoradiographic localization of opiate receptors in rat brain, spinal cord and lower medulla. Brain Res 1977;124:53-67.
9. Krames ES. Intrathecal infusional therapies for intractable pain: patient management guidelines. J Pain Symptom Manage 1993;8:36-46.
10. Manfredi PL, Chandler SW. Prospective review of inpatients consulted on a pain service in a tertiary cancer treatment cancer. Poster Abstracts, American Pain Society Annual Meeting, Miami, FL 1994.
11. Dyer RA, Anderson BJ, Michell WL, Hall JM. Postoperative pain control with a continuous infusion of epidural sufentanil in the intensive care unit: a comparison with epidural morphine. Anesth Analg 1990;71:130-136.
12. Van der Awera D, Verborgh C, Camu F. Analgesic and cardiorespiratory effects of epidural sufentanil and morphine in humans. Anesth Analg 1987; 66:999-1003.
13. Sinatra RS, Sevarino FB, Chung JH, Graf G, Paige D, Takla V, Silverman DG. Comparisons of epidurally administered sufentanil, morphine, and sufentanil-morphine combinations for post-operative analgesia. Anesth Analg 1991;72:522-527.
14. Eisenach JC. Epidural and spinal opioids. In: Barash P, ed. ASA. Philadelphia: Lippincott, 1993: 65-79.
15. Boersma FP, Noourdin H, Bussche G. Epidural sufentanil for cancer pain control in outpatients. Reg Anesth 1989;14:293-297.
16. Samuelsson H, Nordberg G, Hedner T, Lindqvist J. CSF and plasma morphine concentrations in cancer patients during chronic epidural morphine therapy and its relation to pain relief. Pain 1987;30:303-310.
17. Swenson C, Patt RB. Manufacturing Processes. In: Patt RB, ed. Cancer Pain. Philadelphia: Lippincott, 1993:614.
18. American Society of Hospital Pharmacists. ASHP technical assistance bulletin on quality assurance for pharmacy-prepared sterile products. Am J Hosp Pharm 1993;50:2386-2398.